Original Research
This study aims to describe real-world use and outcomes of patients with rheumatoid arthritis prescribed repository corticotropin injection in clinical practice through retrospective analysis of an electronic medical record database.
Corrigendum
The authors wish to make the following corrections to their article: Wan GJ, Chopra I, Niewoehner J, Hunter SF. Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis. Drugs in Context 2020; 9: 2020-9-4. DOI: 10.7573/dic.2020-9-4
Original Research
The objective of this study was to estimate the cost per response of repository corticotropin injection compared with plasmapheresis or intravenous immunoglobulin from the United States commercial payer perspective.
